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In the field of biomaterial advancements, scientists are 
witnessing a golden era in the developments of novel and 
innovative materials for bone repair and regeneration. 
With a global population on the rise and significant 
increase in the number of middle-class citizens capable of 
spending, people are becoming more aware of available 
restorative surgeries that can increase an individual’s qual-
ity of life. Among these, one of the most common and 
practical surgeries is the use of dental implants. Depending 
on the patients’ condition, generally for a dental implant to 
be successfully integrated with the jawbone, first there 
must be enough bone to support the implant. In instances 
where there is tooth loss caused by either periodontal dis-
ease, dental caries and infections, injury, or trauma, bone 
augmentation procedures are required to generate more 
bone to the jaw before implants can be placed. This 
requires surgical implantation of bone graft materials, such 
as tricalcium phosphates (TCPs), to allow new bone to 
grow, a process that can take between 4 and 9 months.1 
Under the right condition, if accelerating the restoration of 
bone can decrease the recovery time, this will be a more 
ideal scenario for both the patient and health-care pro-
vider. The bone regeneration process is complex and is the 
subject of intense focus of research. From a material 
development perspective, TCPs have been extensively 
researched and used with success and safety in the clinical 
environment.2,3 Focus has shifted to making these 
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Abstract
The aim of this study was to examine the bone regeneration properties of beta-tricalcium phosphate hydrothermally 
converted from foraminifera carbonate exoskeleton in the repair of rat calvarial defect. These natural materials possess 
unique interconnected porous network with uniform pore size distribution, which can be potentially advantageous. In 
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the course of the experiment in the beta-tricalcium phosphate group. No soft tissue reaction was observed around the 
beta-tricalcium phosphate implant and the rats remained healthy. These results showed that repair of the calvarial defect 
can be achieved by biomimetic beta-tricalcium phosphate macrospheres, which hold potential for application as bone 
grafts for bone augmentation surgeries.
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materials more bioactive by incorporating pharmaceutics 
(simvastatin, bisphosphonates),4–6 proteins (bone morpho-
genetic proteins (BMPs)),7–9 and bioinorganics (strontium, 
magnesium, fluoride).10–13 While these stimulants do pro-
mote bone regeneration, the morphological features of the 
graft material are equally important, as bone formation 
requires the graft material to be porous to allow ingrowth 
of new bone and blood vessels. In addition, a spherical 
structured material would potentially be more advanta-
geous as it has a higher contact surface area and can con-
form easier to the defect site. In previous studies, our group 
has identified a class of foraminifera carbonate exoskele-
ton possessing a natural spherical structure consisting of 
interconnected and uniform porous network that can be 
hydrothermally converted to beta-tricalcium phosphate (β-
TCP) while preserving the original architecture.12 This 
study will hence evaluate the bone regeneration ability of 
biomimetic β-TCP derived from foraminifera in a rat cal-
varial defect model.
Materials and methods
Synthesis of coralline β-TCP macrospheres
Foraminifera samples (Okinawa Business Support, 
Okinawa, Japan) were cleansed in sodium hypochlorite 
for 30 min to remove any residual contaminants and 
washed thrice in a sonicated water bath. Hydrothermal 
conversion was based on previously established proto-
col.14 In brief, the samples were mixed with aqueous 
diammonium hydrogen phosphate (Wako Chemical Co., 
Tokyo, Japan) in a pressurized vessel where the Ca/P 
molar ratio was adjusted to 1.5 to produce β-TCP. The 
samples were heated to 220°C for 48 h and subsequently 
washed and dried.
Physicochemical characterization
The crystallographic structure of the sample was evaluated 
by powder X-ray diffraction (XRD) analysis (RINT-
Ultima-III; Rigaku Co., Tokyo, Japan; CuKα radiation, 40 
kV, 40 mA) and peak pattern matched with JCPDS data-
base. The structural morphology of the material was 
observed under a scanning electron microscope (SEM) 
(JEOL JSM-7600F field emission SEM, 10 kV, Tokyo, 
Japan) at various magnifications. The in vitro degradation 
of the material and corresponding cellular response with 
bone marrow stromal cells and osteoblasts were examined 
in previous studies.12 The ionic composition of the sample 
material was evaluated by inductively coupled plasma-
mass spectroscopy (ICP-MS). An Agilent Technologies 
(Sydney, Australia) 7500ce series ICP-MS was used with 
sample introduction via a MicroMist concentric nebulizer 
(Glass Expansion) and a Scott-type double-pass spray 
chamber cooled to 2°C. The sample solution and the spray 
chamber waste were carried with the aid of a peristaltic 
pump. The ICP operating parameters and the lens condi-
tions were selected to maximize the sensitivity of a 1% 
HNO3: 1% HCl solution containing 1 ng/mL of Li, Co, Y, 
Ce, and Tl. Helium was added into the octopole reaction 
cell to reduce interference. Calibration curves were con-
structed and the results were analyzed using Agilent 
Technologies MassHunter software. Approximately 0.005 
g of sample was digested with 0.25 mL of 1% HNO3. Once 
the digestion was completed, the sample volume was made 
up with 5 mL water. The samples underwent a further 
1:100 dilution with a 1% nitric acid solution before 
ICP-MS analysis. Samples were diluted further in nitric 
acid as required.
Animals, surgical procedure, and experimental 
design
The Animal Ethics Committee at Musashino University 
approved the animal experiments described herein. In 
total, 20 male Wistar rats (15 weeks old) were randomly 
divided into two groups: (1) control (empty defect) and (2) 
β-TCP. The animals were anesthetized by a combination 
of ketamine (40 mg/kg) and xylazine (5 mg/kg) injected 
intramuscularly. A cutaneous flap was created by making a 
mid-coronal incision through the skin, which was raised 
from the forehead. The periosteum was incised and ele-
vated to expose the calvarial bone on both sides of the mid-
line. One symmetrical, full-thickness bone defects with 
outer diameter of 5 mm were created with a bone trephine 
bur under continuous saline irrigation. Defects were either 
left empty or filled with five β-TCP samples. X-ray scans 
were taken every 2 weeks, and the animals were sacrificed 
at 6 weeks post surgery and evaluated histologically and 
radiologically.
Radiologic assessment of bone formation
The changes in the bone ingrowth area around the graft 
material, bone mineral density (BMD), and bone mineral 
content (BMC) were assessed radiologically by X-ray 
computed tomography (CT) scans (LaTheta LCT-200; 
Hitachi Aloka Medical, Ltd., Tokyo, Japan) taken at 0, 2, 
4, and 6 weeks after grafting. Qualitative images of the 
defect were observed by 3D reconstructed images based 
on commercial 3D software (VGStudio MAX 2.0; Tokyo, 
Japan).
Histological assessment of defect
Histological analysis was performed at 6 weeks after graft-
ing. The retrieved specimens of the rat calvaria were ini-
tially stripped of soft tissues and then fixed in 10% formalin 
solution (Wako Chemical Co. Ltd, Tokyo, Japan) for 2 
weeks. The samples were then dehydrated in graded series 
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of alcohol solution (60%–100%). Finally, the samples 
were embedded in paraffin where the blocks were sec-
tioned using a micro-grinding machine. A series of 5 µm 
thick section were obtained and stained with hematoxylin 
and eosin (H&E). Histomorphometric analyses were per-
formed using transmission light microscopy.
Statistical analysis
Statistical analysis was performed by using SPSS Ver. 11.5 
for Windows. Analysis of variance (ANOVA) with Scheffe 
test was used for comparing the significance among the 
groups at each time point and was expressed as mean ± 
standard deviations. In all cases, a p value of less than 0.05 
was considered statistically significant.
Results
Characterization of the material
The change in the crystallographic structure from carbon-
ate foraminifera to β-TCP was verified by JCPDS data-
base–matched peak patterns as illustrated in Figure 1. The 
spectra showed that the majority of the matched peaks are 
associated with β-TCP, with minor amount of calcium car-
bonate (aragonite: [3,0,0]) remaining in the crystal struc-
ture. In Figure 2, SEM micrographs show the morphological 
structure of both foraminifera and β-TCP material to pos-
sess uniform distribution of pores on the surface of the 
material and most importantly the preservation of these 
features after the conversion process. High-magnification 
image (4000×) of β-TCP showed the pore size of 
the material to be approximately 1 µm in diameter. In a 
previously published study (Chou et al., 2013), it was 
found that the surface pores were interconnected internally 
via porous chambers that are connected to a central porous 
hub.
Animal welfare and care
The surgical process of creating a calvarial defect can 
induce significant stress and trauma to the animal, and as 
such, all of the rats were kept in individual cages through-
out the experimental period to allow space to recover indi-
vidually. Figure 3 presents the CT images showing the 
location of the created defect site in the control (Figure 
3(a)) and β-TCP (Figure 3(b)) groups. The rats were 
monitored on a weekly basis for the duration of the experi-
mental period, and no histopathologic features of graft-
versus-host disease or immune rejection were observed in 
any of the treatment and control groups. Figure 3(c) shows 
a healthy and consistent body weight growth during the 
experimental period in both experimental groups.
Radiological assessment of bone formation
The BMC, which corresponds to the amount of new 
bone formed within the calvarial defect (Figure 4(a)), 
showed that by 2 weeks post surgery, the β-TCP group 
induced statistically significant bone growth compared 
with 0 week. This significant rate of bone formation was 
maintained for the duration of 6-week experimental 
period. Compared with the empty control group which 
only displays a statistically significant bone formation at 
4-week which at 6-week did not show further bone 
growth.
The data presented in Figure 4(b) illustrate the bone 
volume/total volume (BV/TV) at the defect site that 
corresponds to the percentage of the defect filled with 
bone. It should be noted that for the β-TCP sample, at 0 
week, the percentage filled was 70%, corresponding to 
the volume of the sample rather than bone. At 2 weeks, 
the control group’s BV/TV was at 17%, which did not 
change significantly till the end of the experiment. At 0 
week, the β-TCP samples covered ~70% of the defect, 
which quickly increased to 94% by 2 weeks, which is in 
agreement with the BMC results. By 4 weeks, the BV/
TV for β-TCP was 109% and remained the same until 6 
weeks. This suggests that the defect was completely 
filled with bone by 4 weeks along with the embedded 
β-TCP. It should be noted that when the β-TCP was 
implanted, the samples were slightly bigger than the 
defect area and therefore the final calculated BV/TV 
was over 100%. This can be further visualized in later 
figures.
The BMD results (Figure 4(b)) show the control group 
to maintain a non-significant level of BMD (~700 mg/
Figure 1. XRD peak patterns showing matched peak of the 
sample after hydrothermal conversion to β-TCP.
XRD: X-ray diffraction; TCP: tricalcium phosphate.
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cm3), which remained at similar levels throughout the 
experimental period of 6 weeks. β-TCP showed significant 
increase in BMD between 0 (867 mg/cm3) and 6 weeks 
(997 mg/cm3).
Figure 5 shows progressive bone restoration at the 
defect site viewed from the top, and Figure 6 shows coro-
nal view of the progressive bone restoration at the defect 
site. The restoration of bone at the defect site in the control 
group plateaued around 4 weeks with no significant 
changes observed at 6 weeks. This again is in agreement 
with the presented BMC and BV/TV data. It can be clearly 
seen from the images that in the β-TCP group, at 2 weeks, 
the empty space in the defect has been covered, and at 4 
weeks, the bone restored was able to cover the entire 
defect, which again correlates with the corresponding 
BMC and BV/TV data.
Figure 3. Software reconstructed image showing (a) empty defect in the control group, (b) implantation of β-TCP specimens, and 
(c) the preservation of the rat body weight during the study.
β-TCP: beta-tricalcium phosphate.
Figure 2. Scanning electron micrographs showing the preservation of the material after hydrothermal conversion. High-magnification 
images at 400× show the uniform pore distribution through the surface of the material and at 4000× the uniformity of the pores.
B-TCP: Beta-tricalcium phosphate; CaCO3: Calcium carbonate.
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Histological findings
Figure 7 shows the H&E stained samples of the empty 
control and β-TCP groups at 6 weeks. The images show 
similar bone restoration of the defect site as observed in 
the previous CT images. In the control group (Figure 7(a)), 
minimal bone restoration was observed at the center of the 
defect. The β-TCP samples (Figure 7(b)) showed that the 
defect was completely restored with new bone to the same 
level of the original bone thickness. On closer observation 
of the β-TCP samples, it can be seen that the new bone 
infiltrated throughout the material suggesting a good inte-
gration between β-TCP and the surrounding tissue. 
Furthermore, the internal porous chamber structure can be 
observed from the image.
Figure 4. Analysis of the bone defect showing (a) the bone mineral content to be significantly higher in β-TCP group starting from 
2 weeks compared with control, (b) the percentage area of the defect filled with new bone (BV/TV) showing the defect in β-TCP 
group to be 94% filled with new bone and samples by 2 weeks, and (c) the bone mineral density data showing β-TCP to display 
significant levels at 6 weeks compared with control.
β-TCP: beta-tricalcium phosphate; BV/TV: bone volume/total volume.
Figure 5. CT images showing the overall recovery of the 
calvarial defect. Control group showed minimal recovery, 
while β-TCP showed bone recovery from 2 weeks.
β-TCP: beta-tricalcium phosphate; CT: computed tomography.
Figure 6. Software reconstructed coronal image of the center 
of the defect shows the empty control to achieve only minor 
bone restoration, while β-TCP showed defect closure by 2 
weeks and thickening of the bone continuing till 6 weeks.
β-TCP: beta-tricalcium phosphate.
Figure 7. H&E stained slice showing minimal bone restoration 
in the empty control group, while β-TCP showed complete 
recovery of the defect with bone infiltrating the interior 
chambers of the material.
H&E: Hematoxylin and eosin; β-TCP: beta-tricalcium phosphate.
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Discussion
The need for a biologically active bone graft substitute is 
an ongoing challenge for both biomaterial scientist and 
clinicians, and while suitable materials are available on 
the market, areas for improvements are still required. 
Calcareous material originating from the marine environ-
ment has shown to possess unique structural proper-
ties15–17 that can be adapted for biomedical purposes. The 
use of hydrothermal treatment as a process for converting 
calcareous materials to biocompatible calcium phosphates 
has been well documented18–20 and has been shown to pre-
serve the fidelity of the original structure. Crystallographic 
evaluation by XRD showed the main crystalline phase of 
the foraminifera material to be calcium carbonate in the 
form of aragonite [JCPDS-00-0586] and TCP [JCPDS-
00900169] after the hydrothermal treatment. While the 
spectra did show minor retention of the carbonate struc-
ture, it should be noted that the inorganic phase of the 
human bone is carbonated allowing the calcium phos-
phate material to be more osteoconductive and more 
resorbable than stoichiometric hydroxyapatite.21
SEM images showed that the structure of the materials 
was preserved during the conversion process and most 
importantly the pores were uniform in size and well distrib-
uted throughout the surface of the material. This is a crucial 
factor as uniform pore size can potentially allow better 
infiltration of bone cells resulting in faster bone integration 
between the material and the surrounding environment. The 
interconnectivity of these porous chambers is one of the key 
attractiveness in the potential use of these materials as bone 
remodeling cells are able to adhere and proliferate allowing 
bone formation and infiltration of blood vessels.22
The aim of this study was to evaluate the bone regenera-
tive properties of using biomimetic foraminifera calcareous 
exoskeleton as a scaffold for bone restoration in a rat calva-
rial defect model. Following implantation of the β-TCP 
samples into the defect, the conditions of the rats were care-
fully monitored and showed no sign of inflammation or 
material rejection during the 6-week implant period. In the 
defect site, the BMC showed significant bone growth in the 
presence of the β-TCP starting from 2 weeks post opera-
tion. This shows a much higher rate of bone healing of the 
defect compared with the empty control group. We hypoth-
esize that this observation is the result of the β-TCP mate-
rial acting as a scaffold capable of stimulating the localized 
environment through the natural release of calcium and 
phosphate ions as the material degrades and reabsorbed by 
osteoclast cells. This can potentially accelerate the bone 
remodeling process thereby promoting bone regeneration 
of the rat calvarial defect. The uniformity and the intercon-
nectivity of the pores from the β-TCP may also allow for 
increased cell infiltration into the material, which again 
contributes to the overall bone restorative process.
While the promotion of new bone mineral is crucial, the 
change in BMD is equally important. The BMD levels in 
the control group showed no significant changes, which 
can be explained by the lack of bone restoration at the 
defect site. β-TCP on the other hand displayed gradual 
increase in BMD during the experimental period, and at 6 
weeks, significant BMD levels were observed. These 
results suggest that the β-TCP material was able to initiate 
an accelerated bone formation at the defect site during 2–4 
weeks, and between 4 and 6 weeks, the bone mineral 
became denser as a result of continuous bone formation. 
This is also reflected in the BV/TV results showing that 
94% of the defect was filled at 2 weeks, and by 4 weeks, 
the defect has completely recovered.
An overview of the defect site detailing the bone resto-
ration shown in the CT images in Figure 5 reinforces the 
discussed BMC, BMD, and BV/TV results that the β-TCP 
displayed complete closure of the defect by 2 weeks. The 
empty control group, without any material to stimulate the 
bone remodeling process, showed a much slower rate of 
healing with a maximum of ~17% of the defect being 
restored during 6 weeks. Given more time, the defect may 
eventually be restored.
As previously discussed, H&E stained samples showed 
similar observation as those from the CT images. The 
newly formed bone in the β-TCP group was potentially 
thicker than the original calvarial bone and is regularly 
arranged. Furthermore, new bone can be seen infiltrating 
the β-TCP material completely displaying the porous 
chambers of the material at the same time. This suggests a 
good tissue–material integration and the biocompatibility 
of the β-TCP samples.
The presented results are consistent with the regenera-
tive properties of synthetically produced β-TCP material 
in the restoration of bone defects.23,24 This study demon-
strates that a material derived from the natural marine 
environment can possess the same stimulatory properties 
on bone formation. Furthermore, traditional production of 
β-TCP material requires high-temperature sintering 
between 800°C and 1000°C compared with the 200°C 
required for hydrothermal treatment.11,25 Current and 
future studies will require investigating the cellular mech-
anism and pathways involved in the actions of the β-TCP 
material observed in this study and comparing it with clini-
cally used β-TCP samples.
The results presented in this study suggest the therapeu-
tic potentials of using marine-derived β-TCP from 
foraminifera in the restoration of bone in a rat calvarial 
defect. While it is not envisaged that the material will 
replace traditional production of β-TCP grafts, the aim of 
this study is intended to provide an alternative source of 
improved biomaterial for bone restoration applications.
Conclusion
This study showed that foraminifera calcareous exoskel-
eton can be converted to biocompatible β-TCP while 
preserving the interconnected porous architecture. 
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Evaluating the bone regeneration abilities of the material 
in a rat calvarial defect model, the results illustrated a 
faster bone regeneration rate compared with empty con-
trol group while maintaining a steady inclination toward 
BMD. With these, it is envisioned that this material can 
be potentially advantageous for use as a bone graft for 
bone augmentation surgeries or maxillofacial and crani-
ofacial applications.
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